Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 18, 959-967, September 1, 1958]
© 1958 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ultmann, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ultmann, J. E.

The Role of the Spleen in the Hemolytic Anemia of Cancer Patients*

John E. Ultmann

( Department of Medicine, Columbia University College of Physicians and Surgeons and the Medical Services, Francis Delafield and Presbyterian Hospitals, New York, N.Y.)

It has been demonstrated that hemolysis contributes significantly to the anemia of malignancy. The present study was undertaken to determine the role of the spleen in this hemolytic process.

Following injection of Cr51-labeled erythrocytes, the change in radioactivity, with time, above the heart, spleen, and liver was determined by using a body-surface counting technic.

In subjects with normal red cell survival, the ratios of spleen/heart (Sp/H) and of liver/heart (L/H) counts at zero time are less than one, and neither ratio increases significantly above one with time.

In a patient with congenital spherocytic anemia and in a patient with idiopathic Coombs-positive hemolytic anemia, maximal Sp/H ratios were significantly greater than simultaneous L/H ratios, confirming the findings reported in the literature.

In most patients with malignant tumors and shortened red cell survival, but negative Coombs tests, there was also found a moderate to marked increase of radioactivity over the spleen. It is concluded that, in the hemolytic anemia of many patients with malignant tumors, the spleen plays an active role in the removal of red blood cells.

* Presented in part at the annual meeting of the American Association for Cancer Research, Philadelphia, Pennsylvania, April 11, 1958.

This work was supported in part by a grant (C 2332) from the National Cancer Institute of the National Institutes of Health, United States Public Health Service.

Received 5/ 5/58.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1958 by the American Association for Cancer Research.